Valproic Acid Regulates alpha-Synuclein Expression through JNK Pathway in Rat Primary Astrocytes
Biomolecules & Therapeutics
; : 222-228, 2013.
Article
en En
| WPRIM
| ID: wpr-202360
Biblioteca responsable:
WPRO
ABSTRACT
Although the role of alpha-synuclein aggregation on Parkinson's disease is relatively well known, the physiological role and the regulatory mechanism governing the expression of alpha-synuclein are unclear yet. We recently reported that alpha-synuclein is expressed and secreted from cultured astrocytes. In this study, we investigated the effect of valproic acid (VPA), which has been suggested to provide neuroprotection by increasing alpha-synuclein in neuron, on alpha-synuclein expression in rat primary astrocytes. VPA concentration-dependently increased the protein expression level of alpha-synuclein in cultured rat primary astrocytes with concomitant increase in mRNA expression level. Likewise, the level of secreted alpha-synuclein was also increased by VPA. VPA increased the phosphorylation of Erk1/2 and JNK and pretreatment of a JNK inhibitor SP600125 prevented the VPA-induced increase in alpha-synuclein. Whether the increased alpha-synuclein in astrocytes is involved in the reported neuroprotective effects of VPA awaits further investigation.
Palabras clave
Texto completo:
1
Índice:
WPRIM
Asunto principal:
Enfermedad de Parkinson
/
Fosforilación
/
Acetilación
/
ARN Mensajero
/
Astrocitos
/
Ácido Valproico
/
Fármacos Neuroprotectores
/
Sistema de Señalización de MAP Quinasas
/
Alfa-Sinucleína
/
Neuronas
Límite:
Animals
Idioma:
En
Revista:
Biomolecules & Therapeutics
Año:
2013
Tipo del documento:
Article